However, of interest is that at age 3, larger discrepancies in effects of these two markers were observed between the AT and AW tests, an observation that is apparent in the AP test which displays significant evidence of stratification.
Immunohistochemically, cell damage markers were observed.
Further, accession-specific markers were observed in eight accessions.
At BC3F1 generation, a total of 120 alleles from 60 markers were observed.
Significant alterations in some biochemical markers were observed and associated to combined exposure to pollutants.
Upon application of selective agonists no significant changes in TEER or the transport of the paracellular markers were observed.
In osteogenic tube cultures, both early and late osteogenic markers were observed and were reminiscent of in vivo expression pattern.
Significant increases in oxidative damage markers were observed in breast carcinoma patients compared with the normal controls, which were accompanied by significant decrease in TAS.
Further, an increased expression of astrocyte (GFAP) and microglial (Iba-1) activation markers were observed in terms of mRNA and protein levels in the PTZ treated animals.
Moreover, no increases in the levels of hepatic and renal toxicity markers were observed, demonstrating no significant signs of short-term toxicity.
The activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, glutathione-S-transferase and the levels of reduced glutathione were decreased while increases in the levels of lipid peroxidation markers were observed in aortic tissues of diabetic rats.
